98 related articles for article (PubMed ID: 24137971)
61. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo.
Shimura S; Okubo T; Maeda S; Aoki T; Tomioka M; Shindo Y; Takishima T; Umeya K
Biorheology; 1983; 20(5):677-83. PubMed ID: 6375756
[TBL] [Abstract][Full Text] [Related]
62. Safety of ambroxol in the treatment of airway diseases in adult patients.
Cazan D; Klimek L; Sperl A; Plomer M; Kölsch S
Expert Opin Drug Saf; 2018 Dec; 17(12):1211-1224. PubMed ID: 30372367
[TBL] [Abstract][Full Text] [Related]
63. The sulphoxidation of S-carboxymethyl-L-cysteine in COPD.
Steventon GB; Mitchell SC
Eur Respir J; 2006 Apr; 27(4):865-6. PubMed ID: 16585098
[No Abstract] [Full Text] [Related]
64. [Ambroxol. Prophylaxis and therapy of pulmonary complications. Symposium on the occasion of the 12th International Sylt Week on Anesthesiology. 9 September 1998].
Anaesthesist; 1998 Nov; 47(11 Suppl Prophylaxe):1-12. PubMed ID: 9884733
[No Abstract] [Full Text] [Related]
65. Treating critically ill patients with sugar pills.
Colquhoun D
Chest; 2007 Feb; 131(2):635-6; author reply 636. PubMed ID: 17296675
[No Abstract] [Full Text] [Related]
66. Mucolytics for COPD: negotiating a slippery slope towards proof of efficacy.
Aaron SD
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025882
[No Abstract] [Full Text] [Related]
67. Ambroxol, the cough expectorant with neuroprotective effects.
Patzwaldt K; Castaneda-Vega S
Neural Regen Res; 2024 Nov; 19(11):2345-2346. PubMed ID: 38526267
[No Abstract] [Full Text] [Related]
68. Safety Profile of Cough and Cold Medication Use in Pediatrics.
Green JL; Wang GS; Reynolds KM; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Dart RC
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562262
[TBL] [Abstract][Full Text] [Related]
69. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of antitussive agents in man.
Parvez L; Vaidya M; Sakhardande A; Subburaj S; Rajagopalan TG
Pulm Pharmacol; 1996; 9(5-6):299-308. PubMed ID: 9232667
[TBL] [Abstract][Full Text] [Related]
71. Role of mucolytics in wet cough.
Dhar R
J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
[No Abstract] [Full Text] [Related]
72. Effect of bromhexine on the incidence of postoperative bronchopneumonia after upper abdominal surgery.
Hargrave SA; Palmer KN; Makin EJ
Br J Dis Chest; 1975 Jul; 69():195-8. PubMed ID: 811237
[TBL] [Abstract][Full Text] [Related]
73. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
74. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
75. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
76. [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].
Nurgozhin TS; Guliaev AE; Ermekbaeva BA; Zhaugasheva SK; Abuova GT; An ÉA
Klin Med (Mosk); 2013; 91(6):50-5. PubMed ID: 24417069
[TBL] [Abstract][Full Text] [Related]
77. [Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Leshchenko IV
Ter Arkh; 2013; 85(10):83-7. PubMed ID: 24437224
[TBL] [Abstract][Full Text] [Related]
78. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
79. [The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease].
Grigor'eva NIu; Kuznetsov AN; Koroleva TV; Koroleva ME
Ter Arkh; 2013; 85(8):91-4. PubMed ID: 24137971
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
